Zenicor Medical Systems AB (ZENI) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Software Products

Market cap

SEK 19 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.31

Return on Equity

-0.95%

Price to Book

0.48

Revenue and Profits:

Net Sales:

7 Million

(Quarterly Results - Jun 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-44.91%

6 Months

-32.0%

1 Year

-40.5%

2 Years

-76.2%

3 Years

-95.71%

4 Years

-93.16%

5 Years

-86.46%

Zenicor Medical Systems AB for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

7.95%

EBIT Growth (5y)

15.55%

EBIT to Interest (avg)

-0.32

Debt to EBITDA (avg)

6.30

Net Debt to Equity (avg)

0.73

Sales to Capital Employed (avg)

0.54

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

2.18%

ROE (avg)

0.91%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.47

EV to EBIT

20.34

EV to EBITDA

5.19

EV to Capital Employed

0.59

EV to Sales

1.14

PEG Ratio

Dividend Yield

ROCE (Latest)

2.88%

ROE (Latest)

-1.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 9.37% vs 4.92% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 75.00% vs 55.56% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.00",
          "val2": "6.40",
          "chgp": "9.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "1.10",
          "chgp": "9.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.40",
          "val2": "0.50",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.10",
          "val2": "-0.40",
          "chgp": "75.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.90%",
          "val2": "15.80%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 4.13% vs 12.56% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 62.50% vs -229.41% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "25.20",
          "val2": "24.20",
          "chgp": "4.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.20",
          "val2": "-2.60",
          "chgp": "146.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "1.60",
          "chgp": "43.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.10",
          "val2": "-5.60",
          "chgp": "62.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.90%",
          "val2": "-172.50%",
          "chgp": "17.74%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

7.00

6.40

9.37%

Operating Profit (PBDIT) excl Other Income

1.20

1.10

9.09%

Interest

0.40

0.50

-20.00%

Exceptional Items

0.00

Consolidate Net Profit

-0.10

-0.40

75.00%

Operating Profit Margin (Excl OI)

11.90%

15.80%

-0.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 9.37% vs 4.92% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 75.00% vs 55.56% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

25.20

24.20

4.13%

Operating Profit (PBDIT) excl Other Income

1.20

-2.60

146.15%

Interest

2.30

1.60

43.75%

Exceptional Items

0.00

Consolidate Net Profit

-2.10

-5.60

62.50%

Operating Profit Margin (Excl OI)

4.90%

-172.50%

17.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 4.13% vs 12.56% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 62.50% vs -229.41% in Dec 2023

All Annual Results

Company CV

About Zenicor Medical Systems AB

Zenicor Medical Systems AB

Software Products

Zenicor Medical Systems AB is a Sweden-based medical technology company, which is active in the field of diagnosis of arrhythmias and stroke prevention for health care. The Company’s primary product is Zenicor-ECG system, which enables investigations where the patient can register electrocardiography (ECG) data during extended time periods - several times daily and when symptoms are experienced - and transfer the data to a central ECG database, where it is available for the care provider via Internet. The system consists of two main components: Handheld ECG device and Web-based service, Zenicor-ECG Doctor System. Zenicor-ECG is established in more than 350 clinics in Northern Europe, Germany, Austria, Switzerland and Great Britain.

Company Coordinates

Company Details

Saltmatargatan 8 2Tr , STOCKHOLM None : 11359

Tel: 46 8 4426860

https://zenicor.se/

Registrar Details